Autopsy report · NCT04420299
Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19
Cause of deathFunding or business
“Lack of funding of the non-commercial sponsor to extend recruitment and reach the target number of patients specified in the protocol.”
Life of this trial
- Ran for about 1 year before it stopped.
- 81 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Fundación de investigación HM
- Sponsor type
- University, hospital or other
- Conditions
- Covid-19
- Interventions
- Bemiparin; Bemiparin
- Participants
- 81
- Sites
- 2
- Countries
- Spain
Trials that died the same way
- Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
“Inadequate patients recruited. Completion of funding” - Safety and Effectiveness of Combined LED Light for the Treatment of Mild to Moderate Plaque Type Psoriasis Vulgaris
“Lack of funding and sponsor decided to not pursue clinical trial” - TRAUMA HELP: Healing and Analgesia With Propranolol
“Lack of eligible patient recruits/feasibility considerations.” - Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test
“The study recruited no participants due to a pre-recruitment decision by the sponsor to not proceed. Factors considered included logistics, resources, and new research data.” - Effect of Intensive Cognitive Rehabilitation on Cognitive, Motor, and Language Functional Networks in Subacute Stroke Patient
“Patients not recruited.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.